Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Aschoff, 81 are a BUY (86.17%), 10 are a HOLD (10.64%), 3 are a SELL (3.19%).
Analyst Jonathan Aschoff works with a stock forecast success ratio of 32.27% fulfilled within 208.92 days on average.
Jonathan Aschoff’s has documented 160 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CYCC, Cyclacel Pharmaceuticals at 03-May-2024.
Analyst best performing recommendations are on PBLA (PANBELA THERAPEUTICS).
The best stock recommendation documented was for PBLA (PANBELA THERAPEUTICS) at 12/18/2023. The price target of $25 was fulfilled within 1 day with a profit of $4.8 (23.76%) receiving and performance score of 237.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
3 years ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
3 years 2 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 3 months 1 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 3 months 1 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 3 months 28 days ago
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Jonathan Aschoff is most bullish on?
Which stock is Jonathan Aschoff is most reserved on?
What Year was the first public recommendation made by Jonathan Aschoff?